Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cell, Molecular, and Tumor Biology

Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells

Zachary C. Hartman, Anna Tsimelzon, Jamal Hill, Yun Zhang, Abhijit Mazumdar, Susan G. Hilsenbeck, Gordon Mills and Powel H. Brown
Zachary C. Hartman
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Tsimelzon
2Baylor College of Medicine, Houston, TX.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamal Hill
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun Zhang
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhijit Mazumdar
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan G. Hilsenbeck
2Baylor College of Medicine, Houston, TX.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Mills
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Powel H. Brown
1University of Texas MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1940-6207.PREV-11-A42 Published October 2011
  • Article
  • Info & Metrics
Loading
Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA

Abstract

Breast cancers are now subdivided into distinct tumor types based upon molecular classification of tumor gene expression. While most breast cancers are driven by estrogen-mediated signaling (estrogen receptor-positive, (ER+) or Luminal-type breast cancers) or by addiction to the HER2 oncogene (HER2+ breast cancer), the essential cellular signals that control the growth of ER-negative and HER2-negative (or basal-type) breast cancers (approximately 15% of all breast cancers), are incompletely understood. Patients with these ER− and HER2− breast cancers have poor outcomes and few available treatment options other than non-specific chemotherapy. To identify novel targets for the treatment and prevention of basal breast cancers, we investigated the activity of inflammatory genes in these cancers, previously linked to the progression of several other types of cancer. To identify critical inflammatory genes in basal breast cancer, we performed univariate t-tests (FDR<.05) on RNA profiles from the Baylor College of Medicine tumor bank (N=106) to identify inflammatory genes (from 226 genes in the KEGG Cytokine-Cytokine Receptor set) that are differentially expressed in ER-negative breast cancers as compared to ER+ or luminal breast cancers. Combining this analysis with analyses of KEGG cytokine pathway genes in the Richardson (GSE5460, N=129), Bild (GSE3143, N=158), Wang (GSE2034, N=287), Børrensen-Dale (GSE19783, N=115), and Chin Datasets (E-TABM-158, N=119), obtained from the Gene Expression Omnibus and ArrayExpress Repositories, we identified a consensus set of 58 inflammatory genes that are differentially expressed in ER-negative breast cancers as compared to ER+ or luminal breast cancers (genes were considered statistically significant if their p-value was less than 0.05 and displayed fold-differences of >1.5 or < 0.7 in at least two of the datasets analyzed). Further analysis of inflammatory gene expression in breast cancer cell lines revealed that 24 of these genes were highly expressed in basal-like cell lines at the RNA and protein level, as compared to luminal-like ER+ breast cancer lines (showing fold-differences of >1.5 or <0.7). To investigate the role these differentially-expressed genes play in regulating cell growth and transformation, we performed shRNA knock-down studies for 18 of these genes. These studies demonstrated that knockdown of many of these inflammatory genes (including IL-6, IL-8, CCL5, BMP2, TNFRSF21) reduced anchorage-independent growth of basal-like breast cancer cell lines. Further investigation of two cytokine genes, IL-6 and IL-8, revealed that autocrine tumor cell production of these cytokines was critical for maintenance of the transformed state of multiple basal-like cancer lines. We also found that combined inhibition of IL-6 and IL-8 using Tet-induced shRNA suppressed anchorage-independent growth more than either alone, suggesting that these cytokines have non-redundant roles in regulating autocrine-mediated cell growth. These findings suggest that these specific inflammatory pathways regulate the growth and maintenance of the transformed phenotype of basal breast cancers. These results suggest that combined inhibition of both IL-6 and IL-8 inflammatory pathways represents a promising strategy to treat or prevent basal breast cancers. These studies were supported by a Susan G. Komen Promise Grant (to PHB and GM).

Citation Information: Cancer Prev Res 2011;4(10 Suppl):A42.

  • Copyright © American Association for Cancer Research
Previous
Back to top
Cancer Prevention Research: 4 (10 Supplement)
October 2011
Volume 4, Issue 10 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells
Zachary C. Hartman, Anna Tsimelzon, Jamal Hill, Yun Zhang, Abhijit Mazumdar, Susan G. Hilsenbeck, Gordon Mills and Powel H. Brown
Cancer Prev Res October 1 2011 (4) (10 Supplement) A42; DOI: 10.1158/1940-6207.PREV-11-A42

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells
Zachary C. Hartman, Anna Tsimelzon, Jamal Hill, Yun Zhang, Abhijit Mazumdar, Susan G. Hilsenbeck, Gordon Mills and Powel H. Brown
Cancer Prev Res October 1 2011 (4) (10 Supplement) A42; DOI: 10.1158/1940-6207.PREV-11-A42
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Cell, Molecular, and Tumor Biology

  • Abstract PL04-02: ATM: Bridging DNA damage responses and metabolic regulation
  • Abstract PR07: Calorie restriction normalizes global microRNA expression by preventing the loss of Dicer expression during mammary tumorigenesis
  • Abstract CN12-03: Epigenetic targets of sulforaphane and epigallocatechin gallate in cancer prevention
Show more Cell, Molecular, and Tumor Biology

Inflammation and Cancer Initiation and Promotion

  • Abstract B34: CD56+ immune cell infiltration is decreased in benign breast lobules with fibrocystic changes
  • Abstract A43: PPARδ promotes colonic inflammation and inflammation-associated tumorigenesis
Show more Inflammation and Cancer Initiation and Promotion

Inflammation and Cancer Initiation and Promotion: Poster Presentations - Proffered Abstracts

  • Abstract B34: CD56+ immune cell infiltration is decreased in benign breast lobules with fibrocystic changes
  • Abstract A41: The ASK1/IKK signaling axis mediates crosstalk between inflammation and apoptosis
  • Abstract A43: PPARδ promotes colonic inflammation and inflammation-associated tumorigenesis
Show more Inflammation and Cancer Initiation and Promotion: Poster Presentations - Proffered Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement